Specialist palliative care is associated with reduced healthcare utilization in patients with advanced esophageal and gastric cancer: a nationwide register-based study
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-025-09587-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Pauliina Kitti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland. pauliina.kitti@hus.fi. Hauptthemen laut MEDLINE: Palliative Care, Esophageal Neoplasms, Stomach Neoplasms, Patient Acceptance of Health Care. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helsingin ja Uudenmaan Sairaanhoitopiiri, Helsingin Yliopisto, University of Helsinki.
Themen: Palliativpflege
Abstract (Originalsprache)
Background and purpose Esophageal and gastric cancer patients, with poor prognoses and complex symptom burdens, require comprehensive end-of-life care. This study evaluated the impact of specialist palliative care (SPC) on end-of-life healthcare utilization. Material and methods We retrospectively analyzed nationwide healthcare utilization data for all adults who died of esophageal or gastric cancer in Finland in 2019, using National Health and Social Care Registers. Patients were compared based on timing of first SPC contact: early (> 30 days before death) or no/late (≤ 30 days).
Results
The cohort included 732 patients (median age 72 years), with 233 (32%) having SPC contact, including 156 (21%) with early SPC. Most patients (79%) had late/no SPC. The median time for first SPC contact was 120 days before death for early SPC group, and 12 days for no/late group, p < 0.001. Early SPC group, compared to no/late SPC, had fewer emergency department contacts (44% vs. 60%, p < 0.001) and secondary care hospitalizations (32% vs. 61%, p < 0.001) in the last month. Early SPC increased access to hospital-at-home (56% vs. 6%, p < 0.001) and SPC wards (19% vs. 4%, p < 0.001). Patients with early SPC died more often in SPC wards (19% vs. 4%, p < 0.001). Overall, 122 (17%) received hospital-at-home care, and were more likely to die at home (19% vs. 11%, p = 0.011) or in SPC wards (15% vs. 5%, p < 0.001).
Conclusions
Few patients with advanced esophageal or gastric cancer receive SPC. Early SPC was associated with reduced healthcare utilization and improved access to SPC services, highlighting the importance of timely SPC initiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy, Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland. pauliina.kitti@hus.fi.
- Department of Radiotherapy, Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland.
- Nordic Healthcare Group, Helsinki, Finland.
- Department of Palliative Care, Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland.
Förderung
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Helsingin Yliopisto
- University of Helsinki
Zitieren
APA
Kitti, P., Anttonen, A., Nuutinen, M., Carpén, T., & Saarto, T. (2025). Specialist palliative care is associated with reduced healthcare utilization in patients with advanced esophageal and gastric cancer: a nationwide register-based study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-09587-3
Vancouver
Kitti P, Anttonen A, Nuutinen M, Carpén T, Saarto T. Specialist palliative care is associated with reduced healthcare utilization in patients with advanced esophageal and gastric cancer: a nationwide register-based study. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-09587-3
BibTeX
@article{Kitti2025,
author = {Kitti, Pauliina and Anttonen, Anu and Nuutinen, Mikko and Carpén, Timo and Saarto, Tiina},
title = {Specialist palliative care is associated with reduced healthcare utilization in patients with advanced esophageal and gastric cancer: a nationwide register-based study},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-025-09587-3}
}
EUVIMED